These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20884009)

  • 1. Tetrahydrobiopterin therapy for phenylketonuria in infants and young children.
    Burton BK; Adams DJ; Grange DK; Malone JI; Jurecki E; Bausell H; Marra KD; Sprietsma L; Swan KT
    J Pediatr; 2011 Mar; 158(3):410-5. PubMed ID: 20884009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sapropterin. Phenylketonuria: for a minority of patients.
    Prescrire Int; 2010 Jun; 19(107):101-4. PubMed ID: 20738029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of sapropterin in the management of phenylketonuria: seven case reports.
    Gokmen Ozel H; Lammardo AM; Motzfeldt K; Robert M; Rocha JC; van Rijn M; Ahring K; Bélanger-Quintana A; MacDonald A; Dokoupil K
    Mol Genet Metab; 2013 Feb; 108(2):109-11. PubMed ID: 23266371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sapropterin: a new therapeutic agent for phenylketonuria.
    Hegge KA; Horning KK; Peitz GJ; Hegge K
    Ann Pharmacother; 2009 Sep; 43(9):1466-73. PubMed ID: 19654333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrahydrobiopterin-responsive phenylketonuria: the New South Wales experience.
    Mitchell JJ; Wilcken B; Alexander I; Ellaway C; O'Grady H; Wiley V; Earl J; Christodoulou J
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S81-5. PubMed ID: 16091307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sapropterin (Kuvan) for phenylketonuria.
    Med Lett Drugs Ther; 2008 Jun; 50(1287):43-4. PubMed ID: 18509266
    [No Abstract]   [Full Text] [Related]  

  • 7. Is sapropterin treatment suitable for all subjects with phenylketonuria?
    Doggrell SA
    Expert Opin Pharmacother; 2008 Jan; 9(1):145-7. PubMed ID: 18076346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study.
    Levy HL; Milanowski A; Chakrapani A; Cleary M; Lee P; Trefz FK; Whitley CB; Feillet F; Feigenbaum AS; Bebchuk JD; Christ-Schmidt H; Dorenbaum A;
    Lancet; 2007 Aug; 370(9586):504-10. PubMed ID: 17693179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to tetrahydrobiopterin therapy in patients with phenylketonuria.
    Rohr F; Wessel A; Brown M; Charette K; Levy HL
    Mol Genet Metab; 2015 Jan; 114(1):25-8. PubMed ID: 25467057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving patient selection and clinical benefit criteria for sapropterin dihydrochloride (Kuvan®) treatment of PKU patients.
    Gordon P; Thomas JA; Suter R; Jurecki E
    Mol Genet Metab; 2012 Apr; 105(4):672-6. PubMed ID: 22310224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria.
    Muntau AC; Röschinger W; Habich M; Demmelmair H; Hoffmann B; Sommerhoff CP; Roscher AA
    N Engl J Med; 2002 Dec; 347(26):2122-32. PubMed ID: 12501224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term developmental progression in infants and young children taking sapropterin for phenylketonuria: a two-year analysis of safety and efficacy.
    Longo N; Siriwardena K; Feigenbaum A; Dimmock D; Burton BK; Stockler S; Waisbren S; Lang W; Jurecki E; Zhang C; Prasad S
    Genet Med; 2015 May; 17(5):365-73. PubMed ID: 25232857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled study.
    Trefz FK; Burton BK; Longo N; Casanova MM; Gruskin DJ; Dorenbaum A; Kakkis ED; Crombez EA; Grange DK; Harmatz P; Lipson MH; Milanowski A; Randolph LM; Vockley J; Whitley CB; Wolff JA; Bebchuk J; Christ-Schmidt H; Hennermann JB;
    J Pediatr; 2009 May; 154(5):700-7. PubMed ID: 19261295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for the use of sapropterin in phenylketonuria.
    Cunningham A; Bausell H; Brown M; Chapman M; DeFouw K; Ernst S; McClure J; McCune H; O'Steen D; Pender A; Skrabal J; Wessel A; Jurecki E; Shediac R; Prasad S; Gillis J; Cederbaum S
    Mol Genet Metab; 2012 Jul; 106(3):269-76. PubMed ID: 22575621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study.
    Burton BK; Grange DK; Milanowski A; Vockley G; Feillet F; Crombez EA; Abadie V; Harding CO; Cederbaum S; Dobbelaere D; Smith A; Dorenbaum A
    J Inherit Metab Dis; 2007 Oct; 30(5):700-7. PubMed ID: 17846916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety and efficacy of sapropterin: the PKUDOS registry experience.
    Longo N; Arnold GL; Pridjian G; Enns GM; Ficicioglu C; Parker S; Cohen-Pfeffer JL;
    Mol Genet Metab; 2015 Apr; 114(4):557-63. PubMed ID: 25724073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sapropterin is safe and effective in patients less than 4-years-old with BH4-responsive phenylalanine hydrolase deficiency.
    Shintaku H; Ohura T
    J Pediatr; 2014 Dec; 165(6):1241-4. PubMed ID: 25223838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spotlight on sapropterin in primary hyperphenylalaninemia.
    Sanford M; Keating GM
    BioDrugs; 2009; 23(3):201-2. PubMed ID: 19627172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Tetrahydrobiopterin treatment of variant form of phenylketonuria.
    Danks DM; Cotton RG; Schlesinger P
    Lancet; 1975 Nov; 2(7943):1043. PubMed ID: 53532
    [No Abstract]   [Full Text] [Related]  

  • 20. Testing for tetrahydrobiopterin responsiveness in patients with hyperphenylalaninemia due to phenylalanine hydroxylase deficiency.
    Cerone R; Andria G; Giovannini M; Leuzzi V; Riva E; Burlina A
    Adv Ther; 2013 Mar; 30(3):212-28. PubMed ID: 23436109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.